BofA raised the firm’s price target on Concentrix to $102 from $85 and keeps a Neutral rating on the shares. The analyst is positive on the company’s relative end-market strength and notes that while the Catalyst business continues to be negatively impacted given the weaker macro, the business could benefit if it gets work related to AI consulting, managed services, curation, and analytics.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>